Acute limb ischemia in nonagenarians

J Cardiovasc Surg (Torino). 2013 Oct;54(5):625-31.

Abstract

Aim: Acute limb ischemia (ALI) is not infrequently associated with limb loss (10-30%) or death of the affected patient (15-30%). These results can be even worse in elderly population. The aim of this study is to quantify safety and efficacy of early revascularization in over 90 years old patients with acute limb ischemia.

Methods: This is a prospective registry lasting from January 2012 to January 2013. We include all consecutive over 90 years patients treated for ALI (N.=15). A careful preoperative Duplex scan (DS) were performed in each patient. All patients underwent surgery by Fogarty's embolectomy, and endovascular completion procedure if needed (N.=3).

Results: We performed 18 revascularizations (15 lower limbs, 3 upper limbs) in 15 patients (2 staged bilateral femoral, 1 simultaneous bilateral femoral). The mean follow-up was 124 days (4-365). Technical success was obtained in 16 cases (88.9%). At disharge mortality was 5.9% (1 case), and amputation rate was 6.2% (1 pt). The Kaplan-Meier curves at 1 year revealed an estimated freedom from death, amputation and re-occlusion of 76.5%, 88.2%, and 71.3%, respectively.

Conclusion: The over 90 years old patient represent a challenging case for vascular surgeon. Vascular procedures involve high mortality rate but emergent revascularization by Fogarty Embolectomy in ALI is safe and effective even in older patient.

MeSH terms

  • Acute Disease
  • Age Factors
  • Aged, 80 and over
  • Amputation, Surgical
  • Disease-Free Survival
  • Embolectomy / adverse effects
  • Embolectomy / methods*
  • Embolectomy / mortality
  • Endovascular Procedures* / adverse effects
  • Endovascular Procedures* / mortality
  • Female
  • Hospital Mortality
  • Humans
  • Ischemia / diagnosis
  • Ischemia / mortality
  • Ischemia / physiopathology
  • Ischemia / surgery
  • Ischemia / therapy*
  • Kaplan-Meier Estimate
  • Limb Salvage
  • Lower Extremity / blood supply*
  • Male
  • Prospective Studies
  • Registries
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Upper Extremity / blood supply*
  • Vascular Patency